Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 22 studies | 28% ± 11% | |
fibroblast | 12 studies | 27% ± 9% | |
glutamatergic neuron | 10 studies | 42% ± 28% | |
GABAergic neuron | 9 studies | 41% ± 25% | |
adipocyte | 9 studies | 28% ± 12% | |
astrocyte | 9 studies | 33% ± 14% | |
oligodendrocyte | 9 studies | 28% ± 9% | |
B cell | 8 studies | 23% ± 8% | |
microglial cell | 8 studies | 30% ± 11% | |
oligodendrocyte precursor cell | 8 studies | 34% ± 15% | |
endothelial cell of lymphatic vessel | 7 studies | 34% ± 13% | |
pericyte | 7 studies | 30% ± 10% | |
macrophage | 7 studies | 30% ± 12% | |
epithelial cell | 6 studies | 38% ± 17% | |
basal cell | 6 studies | 25% ± 16% | |
natural killer cell | 5 studies | 21% ± 5% | |
dendritic cell | 5 studies | 21% ± 6% | |
myeloid cell | 5 studies | 23% ± 4% | |
T cell | 5 studies | 22% ± 6% | |
club cell | 5 studies | 22% ± 8% | |
smooth muscle cell | 5 studies | 25% ± 5% | |
type I pneumocyte | 5 studies | 26% ± 7% | |
type II pneumocyte | 5 studies | 20% ± 6% | |
neuron | 4 studies | 40% ± 14% | |
CD4-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
cardiac muscle cell | 4 studies | 21% ± 1% | |
vein endothelial cell | 4 studies | 31% ± 17% | |
ciliated cell | 4 studies | 23% ± 6% | |
lymphocyte | 4 studies | 33% ± 10% | |
amacrine cell | 4 studies | 22% ± 7% | |
retina horizontal cell | 4 studies | 24% ± 9% | |
interneuron | 4 studies | 53% ± 20% | |
plasma cell | 3 studies | 28% ± 3% | |
retinal pigment epithelial cell | 3 studies | 32% ± 21% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
mesothelial cell | 3 studies | 22% ± 5% | |
retinal bipolar neuron | 3 studies | 19% ± 3% | |
retinal cone cell | 3 studies | 25% ± 10% | |
GABAergic amacrine cell | 3 studies | 21% ± 7% | |
retinal rod cell | 3 studies | 19% ± 1% | |
rod bipolar cell | 3 studies | 25% ± 10% | |
capillary endothelial cell | 3 studies | 19% ± 2% | |
endothelial cell of vascular tree | 3 studies | 30% ± 18% | |
hepatocyte | 3 studies | 51% ± 27% | |
CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
alveolar macrophage | 3 studies | 28% ± 8% | |
monocyte | 3 studies | 26% ± 2% | |
transit amplifying cell | 3 studies | 37% ± 25% | |
granule cell | 3 studies | 22% ± 3% | |
mural cell | 3 studies | 29% ± 11% | |
mucus secreting cell | 3 studies | 24% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3411.98 | 1445 / 1445 | 100% | 35.35 | 183 / 183 |
lung | 100% | 3809.89 | 578 / 578 | 100% | 21.03 | 1153 / 1155 |
ovary | 100% | 4333.52 | 180 / 180 | 100% | 18.36 | 429 / 430 |
breast | 100% | 4218.05 | 459 / 459 | 99% | 41.30 | 1110 / 1118 |
intestine | 100% | 4061.16 | 966 / 966 | 99% | 17.67 | 522 / 527 |
bladder | 100% | 3929.48 | 21 / 21 | 99% | 18.21 | 497 / 504 |
stomach | 100% | 3098.41 | 359 / 359 | 99% | 20.89 | 282 / 286 |
pancreas | 100% | 2688.73 | 328 / 328 | 98% | 16.04 | 174 / 178 |
thymus | 100% | 5697.48 | 653 / 653 | 98% | 17.38 | 590 / 605 |
uterus | 100% | 4836.92 | 170 / 170 | 97% | 17.05 | 444 / 459 |
brain | 97% | 2063.94 | 2558 / 2642 | 99% | 18.18 | 699 / 705 |
prostate | 100% | 3830.44 | 245 / 245 | 96% | 16.99 | 481 / 502 |
skin | 100% | 4110.91 | 1807 / 1809 | 93% | 17.48 | 438 / 472 |
adrenal gland | 100% | 3580.66 | 258 / 258 | 93% | 11.93 | 213 / 230 |
kidney | 100% | 2601.70 | 89 / 89 | 92% | 13.88 | 833 / 901 |
liver | 100% | 1947.92 | 226 / 226 | 74% | 7.63 | 302 / 406 |
adipose | 100% | 4022.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3999.96 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3033.74 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3830.15 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.97 | 1 / 1 |
heart | 98% | 2573.51 | 841 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 17.82 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 90% | 14.91 | 26 / 29 |
eye | 0% | 0 | 0 / 0 | 80% | 11.56 | 64 / 80 |
peripheral blood | 41% | 1460.07 | 385 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005515 | Molecular function | protein binding |
Gene name | TASOR2 |
Protein name | Transcription activation suppressor family member 2 Protein TASOR 2 |
Synonyms | KIAA2006 FAM208B C10orf18 |
Description | |
Accessions | ENST00000695737.1 [Q5VWN6-1] A0A2R8YCL4 ENST00000695834.1 [Q5VWN6-1] ENST00000328090.9 [Q5VWN6-1] A0A8Q3SI84 A0A8V8TMM4 ENST00000463468.5 ENST00000645567.1 ENST00000496681.5 A0A8Q3SI42 A0A1D5RMU0 ENST00000695837.1 A0A2R8YH03 A0A8Q3SI30 ENST00000695832.1 ENST00000699051.1 ENST00000695833.1 ENST00000695835.1 A0A8Q3SI68 ENST00000699050.1 Q5VWN6 ENST00000482419.1 A0A8V8TMN1 A0A8Q3SI29 ENST00000695836.1 A0A2R8YCW7 |